Format

Send to

Choose Destination
Hum Immunol. 2017 Nov;78(11-12):710-717. doi: 10.1016/j.humimm.2017.10.001. Epub 2017 Oct 5.

Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.

Author information

1
DKMS, Tübingen, Germany. Electronic address: solloch@dkms.de.
2
DKMS Life Science Lab, Dresden, Germany.
3
DKMS, Tübingen, Germany; DKMS Life Science Lab, Dresden, Germany.
4
DKMS, Tübingen, Germany.

Abstract

Homozygous carriers of CCR5-Δ32, a gene variant of CC-type chemokine receptor 5 (CCR5), are highly resistant to infections with human immunodeficiency virus type 1 (HIV-1) and therefore preferred stem cell donors for HIV-infected patients. We analyzed CCR5 typing data of 1,333,035 potential hematopoietic stem cell donors enlisted with three national DKMS donor centers. Allele and genotype frequencies were determined for 87 countries of origin as self-assessed by the donors. CCR5-Δ32 allele frequencies ranged from 16.4% in the Norwegian sample to 0 in donors from Ethiopia. The highest CCR5-Δ32/Δ32 genotype frequency was found in the sample from the Faroe Islands (2.3%), whereas in 27 samples, predominantly of donors from Africa, Asia and South America, none of the individuals carried this genotype. The characteristic CCR5-Δ32 allele frequency decline from Northern to Southeastern Eurasia supports findings of earlier studies. With available HLA haplotype frequency information for the patient's ethnicity, our data allows upfront estimation of the probability that an HLA-matched donor with CCR5-Δ32/Δ32 genotype can be found for a patient in need of hematopoietic stem cell transplantation.

KEYWORDS:

CCR5; CCR5-Δ32; HIV-1; HSCT

PMID:
28987960
DOI:
10.1016/j.humimm.2017.10.001
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center